This brochure outlines how MIMETAS supports predictive toxicity testing using physiologically relevant 3D tissue models based on Organ-on-a-Chip technology. Designed for high-throughput workflows, these models offer human-relevant insights that support safer and more efficient drug development.It features applications across four key toxicity areas: blood-brain barrier toxicity, vascular toxicity, neurotoxicity, and intestinal toxicity. Each model enables measurement of relevant functional and structural endpoints, helping researchers detect adverse effects early in the development pipeline.The brochure also introduces the OrganoReady® portfolio—pre-validated, ready-to-use tissue models for common toxicity applications, optimized for use with the OrganoPlate® platform.